Plamsa 5=-AMP (pAMP) and uric acid (UA) elevated in type 2 diabetic

Hyperuricemia and the small intestine: Transport mechanisms and co-morbidities - ScienceDirect

Pharmaceuticals, Free Full-Text

Mechanisms of action of SGLT2 inhibitors. SGLT2 inhibitors lower plasma

AMP-activated protein kinase α2 contributes to acute and chronic hyperuricemic nephropathy via renal urate deposition in a mouse model, European Journal of Medical Research

Hyperuricemia and related diseases. Hyperuricemia occurs as a result of

Uric acid: potential mechanisms for insulin resistance and diabetes.

Nutrients, Free Full-Text

Gut bacteria impact host uric acid burden and its association with atherosclerosis

IJMS, Free Full-Text

JCDD, Free Full-Text

The plasma 5′-AMP acts as a potential upstream regulator of hyperglycemia in type 2 diabetic mice

Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease - ScienceDirect

Nutrients, Free Full-Text

AMP-activated protein kinase α2 contributes to acute and chronic hyperuricemic nephropathy via renal urate deposition in a mouse model, European Journal of Medical Research